The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...
5hon MSN
GSK shares are trading cheaply and offering potential passive income. So is this FTSE 100 stock a no-brainer buy for my ...
NEW YORK, NY / ACCESS Newswire / March 22, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of ‘Nucala’, or ...
GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...
GSK PLC closed 15.77% below its 52-week high of £18.24, which the company reached on May 16th.
London open The FTSE 100 is expected to open 28 points higher on Monday, having closed down 0.63% on Friday at 8,646.79.
Shares of GSK PLC GSK slipped 1.73% to £15.05 Wednesday, on what proved to be an all-around positive trading session for the ...
(Alliance News) - GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstructive pulmonary disease accepted for review by the European ...
After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...
NEW YORK CITY, NY / ACCESS Newswire / March 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results